TIROFIBAN HYDROCHLORIDE MONOHYDRATE

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Warning

• 危険有害性情報

  H302：飲み込むと有害

  H315：皮膚刺激

  H319：強い眼刺激

  H335：呼吸器への刺激のおそれ

• 注意書き

  P261：粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。

  P305+P351+P338：眼に入った場合：水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

TIROFIBAN HYDROCHLORIDE MONOHYDRATE 価格

TIROFIBAN HYDROCHLORIDE MONOHYDRATE 化学特性,用途語,生産方法

• 説明

  Tirofiban was launched as Aggrastat in Switzerland and the US for patients with unstable angina or non-Q-wave myocardial infarction to prevent cardiac ischemic events. Tirofiban is synthesized from (S)-tyrosine by a fourstep process. Tirofiban is a novel highly potent antiplatelet agent that inhibits the interaction of fibrinogen with GPⅡb/Ⅲa, an activated platelet membrane-bound glycoprotein complex. It prevents arterial thrombus formation in a dosedependent manner. Clinical efficacy was highly significant with an absolute and relative risk reduction. In these studies, treatment with tirofiban was well tolerated, without significant adverse effects.

• 使用

  Aggrastat (Millot Laboratories, France).

TIROFIBAN HYDROCHLORIDE MONOHYDRATE 上流と下流の製品情報

TIROFIBAN HYDROCHLORIDE MONOHYDRATE 生産企業

Global(124)Suppliers

142373-60-2, TIROFIBAN HYDROCHLORIDE MONOHYDRATE キーワード